FDA Vaccine Advisers to Discuss Covid-19 Boosters

The U.S. Food and Drug Administration will meet tomorrow to discuss Coronavirus boosters. Yesterday, three reports were published in support of the argument that people may need the third dose of Pfizer’s Covid-19 vaccine over time. The reports are part of a batch of data that will be discussed by the FDA’s vaccine advisers when they consider the request by Pfizer to approve their third dose for most people six months after their second dose of the vaccine during the meeting. Health departments around the country are getting ready to roll out booster doses next week if the FDA gives the green light.

Earlier this week on Monday, a group of international vaccine experts including members of the FDA and World Health Organization said that current evidence does not appear to support a need for booster shots to the general public. Currently only about 54% of the U.S. population is fully vaccinated according to the CDC.